These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 12663508

  • 1. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.
    Gago-Dominguez M, Bell DA, Watson MA, Yuan JM, Castelao JE, Hein DW, Chan KK, Coetzee GA, Ross RK, Yu MC.
    Carcinogenesis; 2003 Mar; 24(3):483-9. PubMed ID: 12663508
    [Abstract] [Full Text] [Related]

  • 2. Carotenoids/vitamin C and smoking-related bladder cancer.
    Castelao JE, Yuan JM, Gago-Dominguez M, Skipper PL, Tannenbaum SR, Chan KK, Watson MA, Bell DA, Coetzee GA, Ross RK, Yu MC.
    Int J Cancer; 2004 Jun 20; 110(3):417-23. PubMed ID: 15095308
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H, Sigsgaard T, Wolf H, Autrup H.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr 20; 6(4):225-31. PubMed ID: 9107426
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer.
    Yuan JM, Chan KK, Coetzee GA, Castelao JE, Watson MA, Bell DA, Wang R, Yu MC.
    Carcinogenesis; 2008 Jul 20; 29(7):1386-93. PubMed ID: 18544563
    [Abstract] [Full Text] [Related]

  • 8. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N.
    Lancet; 2008 Jul 20; 366(9486):649-59. PubMed ID: 16112301
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain.
    Kogevinas M, Fernandez F, Garcia-Closas M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, Yeager M, Chanock SJ, Lloreta J, Rothman N, Real FX, Dosemeci M, Malats N, Silverman D.
    Eur J Cancer; 2006 Jul 20; 42(10):1448-54. PubMed ID: 16740387
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
    Godschalk RW, Dallinga JW, Wikman H, Risch A, Kleinjans JC, Bartsch H, Van Schooten FJ.
    Pharmacogenetics; 2001 Jul 20; 11(5):389-98. PubMed ID: 11470992
    [Abstract] [Full Text] [Related]

  • 14. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ.
    Br J Cancer; 1999 Oct 20; 81(3):537-41. PubMed ID: 10507782
    [Abstract] [Full Text] [Related]

  • 15. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J, Liang D, Wang Y, Lu C, Wu X.
    Mutat Res; 2005 Mar 07; 581(1-2):97-104. PubMed ID: 15725609
    [Abstract] [Full Text] [Related]

  • 16. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S, Blaszkewicz M, Ickstadt K, Hengstler JG, Golka K.
    Arch Toxicol; 2013 Dec 07; 87(12):2129-39. PubMed ID: 24221535
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
    Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL, Bell DA.
    Cancer Res; 1998 Aug 15; 58(16):3603-10. PubMed ID: 9721868
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M, Michaud D, De Vivo I.
    BMC Cancer; 2006 Oct 06; 6():239. PubMed ID: 17026750
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.